Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

Stock Performance and Industry Comparison - Intuitive Surgical, Inc (ISRG) shares returned +3 8% over the past month, underperforming the Zacks S&P 500 composite's +5% change [1] - The Zacks Medical - Instruments industry, which the company belongs to, gained 3 3% during the same period [1] Earnings Estimates and Revisions - The company is expected to post earnings of $1 39 per share for the current quarter, representing a year-over-year change of +13% [3] - The Zacks Consensus Estimate for the current quarter has changed -0 1% over the last 30 days [3] - For the current fiscal year, the consensus earnings estimate of $6 18 points to a change of +8 2% from the prior year, with a -1 3% revision over the last 30 days [3] - The next fiscal year's consensus earnings estimate of $7 27 indicates a change of +17 7% from the prior year, with a -1 9% revision over the past month [3] Revenue Growth Projections - The consensus sales estimate of $1 87 billion for the current quarter points to a year-over-year change of +10 1% [5] - The $7 98 billion and $9 2 billion estimates for the current and next fiscal years indicate changes of +12% and +15 3%, respectively [5] Recent Financial Performance - The company reported revenues of $1 93 billion in the last reported quarter, representing a year-over-year change of +16 5% [6] - EPS of $1 60 for the same period compares with $1 23 a year ago [6] - The reported revenues represent a surprise of +0 02% compared to the Zacks Consensus Estimate of $1 93 billion [6] - The EPS surprise was +8 84% [6] - The company beat consensus EPS estimates in each of the trailing four quarters and topped consensus revenue estimates three times over this period [7] Valuation Metrics - Intuitive Surgical, Inc is graded D on the Zacks Value Style Score, indicating that it is trading at a premium to its peers [9] Investment Consideration - The Zacks Rank 4 (Sell) for Intuitive Surgical, Inc suggests that it may underperform the broader market in the near term [10]